Literature DB >> 16508000

An apparent pseudo-exon acts both as an alternative exon that leads to nonsense-mediated decay and as a zero-length exon.

Sushma-Nagaraja Grellscheid1, Christopher W J Smith.   

Abstract

Pseudo-exons are intronic sequences that are flanked by apparent consensus splice sites but that are not observed in spliced mRNAs. Pseudo-exons are often difficult to activate by mutation and have typically been viewed as a conceptual challenge to our understanding of how the spliceosome discriminates between authentic and cryptic splice sites. We have analyzed an apparent pseudo-exon located downstream of mutually exclusive exons 2 and 3 of the rat alpha-tropomyosin (TM) gene. The TM pseudo-exon is conserved among mammals and has a conserved profile of predicted splicing enhancers and silencers that is more typical of a genuine exon than a pseudo-exon. Splicing of the pseudo-exon is fully activated for splicing to exon 3 by a number of simple mutations. Splicing of the pseudo-exon to exon 3 is predicted to lead to nonsense-mediated decay (NMD). In contrast, when "prespliced" to exon 2 it follows a "zero length exon" splicing pathway in which a newly generated 5' splice site at the junction with exon 2 is spliced to exon 4. We propose that a subset of apparent pseudo-exons, as exemplified here, are actually authentic alternative exons whose inclusion leads to NMD.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16508000      PMCID: PMC1430291          DOI: 10.1128/MCB.26.6.2237-2246.2006

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  43 in total

1.  SC35 autoregulates its expression by promoting splicing events that destabilize its mRNAs.

Authors:  A Sureau; R Gattoni; Y Dooghe; J Stévenin; J Soret
Journal:  EMBO J       Date:  2001-04-02       Impact factor: 11.598

2.  The spliceosome deposits multiple proteins 20-24 nucleotides upstream of mRNA exon-exon junctions.

Authors:  H Le Hir; E Izaurralde; L E Maquat; M J Moore
Journal:  EMBO J       Date:  2000-12-15       Impact factor: 11.598

3.  Multiple splicing defects in an intronic false exon.

Authors:  H Sun; L A Chasin
Journal:  Mol Cell Biol       Date:  2000-09       Impact factor: 4.272

Review 4.  Alternative pre-mRNA splicing: the logic of combinatorial control.

Authors:  C W Smith; J Valcárcel
Journal:  Trends Biochem Sci       Date:  2000-08       Impact factor: 13.807

5.  Evidence for a pioneer round of mRNA translation: mRNAs subject to nonsense-mediated decay in mammalian cells are bound by CBP80 and CBP20.

Authors:  Y Ishigaki; X Li; G Serin; L E Maquat
Journal:  Cell       Date:  2001-09-07       Impact factor: 41.582

6.  Pseudoexon activation as a novel mechanism for disease resulting in atypical growth-hormone insensitivity.

Authors:  L A Metherell; S A Akker; P B Munroe; S J Rose; M Caulfield; M O Savage; S L Chew; A J Clark
Journal:  Am J Hum Genet       Date:  2001-07-20       Impact factor: 11.025

7.  A genomic view of alternative splicing.

Authors:  Barmak Modrek; Christopher Lee
Journal:  Nat Genet       Date:  2002-01       Impact factor: 38.330

8.  Restoration of correct splicing of thalassemic beta-globin pre-mRNA by modified U1 snRNAs.

Authors:  L Gorman; D R Mercatante; R Kole
Journal:  J Biol Chem       Date:  2000-11-17       Impact factor: 5.157

9.  Nuclear antisense effects of neutral, anionic and cationic oligonucleotide analogs.

Authors:  P Sazani; S H Kang; M A Maier; C Wei; J Dillman; J Summerton; M Manoharan; R Kole
Journal:  Nucleic Acids Res       Date:  2001-10-01       Impact factor: 16.971

10.  Differential alternative splicing activity of isoforms of polypyrimidine tract binding protein (PTB).

Authors:  M C Wollerton; C Gooding; F Robinson; E C Brown; R J Jackson; C W Smith
Journal:  RNA       Date:  2001-06       Impact factor: 4.942

View more
  18 in total

1.  A nonsense exon in the Tpm1 gene is silenced by hnRNP H and F.

Authors:  Joel L Coles; Martina Hallegger; Christopher W J Smith
Journal:  RNA       Date:  2008-11-26       Impact factor: 4.942

2.  Molecular biology: Splicing does the two-step.

Authors:  Heidi Cook-Andersen; Miles F Wilkinson
Journal:  Nature       Date:  2015-05-13       Impact factor: 49.962

3.  hnRNP F directs formation of an exon 4 minus variant of tumor-associated NADH oxidase (ENOX2).

Authors:  Xiaoyu Tang; Vanessa D Kane; Dorothy M Morré; D James Morré
Journal:  Mol Cell Biochem       Date:  2011-05-28       Impact factor: 3.396

4.  Common genetic variation in Neuregulin 3 (NRG3) influences risk for schizophrenia and impacts NRG3 expression in human brain.

Authors:  Wee-Tin Kao; Yanhong Wang; Joel E Kleinman; Barbara K Lipska; Thomas M Hyde; Daniel R Weinberger; Amanda J Law
Journal:  Proc Natl Acad Sci U S A       Date:  2010-08-16       Impact factor: 11.205

5.  Unconstrained mining of transcript data reveals increased alternative splicing complexity in the human transcriptome.

Authors:  I G Mollet; Claudia Ben-Dov; Daniel Felício-Silva; A R Grosso; Pedro Eleutério; Ruben Alves; Ray Staller; Tito Santos Silva; Maria Carmo-Fonseca
Journal:  Nucleic Acids Res       Date:  2010-04-12       Impact factor: 16.971

6.  The intronic splicing code: multiple factors involved in ATM pseudoexon definition.

Authors:  Ashish Dhir; Emanuele Buratti; Maria A van Santen; Reinhard Lührmann; Francisco E Baralle
Journal:  EMBO J       Date:  2010-01-21       Impact factor: 11.598

7.  Propionic and methylmalonic acidemia: antisense therapeutics for intronic variations causing aberrantly spliced messenger RNA.

Authors:  A Rincón; C Aguado; L R Desviat; R Sánchez-Alcudia; M Ugarte; B Pérez
Journal:  Am J Hum Genet       Date:  2007-12       Impact factor: 11.025

8.  Genetic variants in S-adenosyl-methionine synthesis pathway and nonsyndromic cleft lip with or without cleft palate in Chile.

Authors:  Carlos Salamanca; Patricio González-Hormazábal; Andrea S Recabarren; Pamela A Recabarren; Roberto Pantoja; Noemi Leiva; Rosa Pardo; José Suazo
Journal:  Pediatr Res       Date:  2020-06-03       Impact factor: 3.756

9.  The peculiarities of large intron splicing in animals.

Authors:  Samuel Shepard; Mark McCreary; Alexei Fedorov
Journal:  PLoS One       Date:  2009-11-16       Impact factor: 3.240

10.  Dual role of G-runs and hnRNP F in the regulation of a mutation-activated pseudoexon in the fibrinogen gamma-chain transcript.

Authors:  Valeria Rimoldi; Giulia Soldà; Rosanna Asselta; Silvia Spena; Cristiana Stuani; Emanuele Buratti; Stefano Duga
Journal:  PLoS One       Date:  2013-03-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.